ConvaTec Group (LON:CTEC) Price Target Raised to GBX 295

ConvaTec Group (LON:CTECGet Rating) had its target price hoisted by investment analysts at Barclays from GBX 290 ($3.34) to GBX 295 ($3.40) in a research report issued on Friday, Marketbeat reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 31.34% from the company’s current price.

CTEC has been the topic of several other research reports. JPMorgan Chase & Co. boosted their target price on ConvaTec Group from GBX 255 ($2.94) to GBX 275 ($3.17) and gave the company an “overweight” rating in a research note on Friday, August 5th. Berenberg Bank boosted their target price on ConvaTec Group from GBX 250 ($2.88) to GBX 280 ($3.22) and gave the company a “buy” rating in a research note on Thursday, September 8th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a GBX 210 ($2.42) target price on shares of ConvaTec Group in a research note on Thursday, August 11th.

ConvaTec Group Trading Down 2.7 %

LON CTEC opened at GBX 224.60 ($2.59) on Friday. The stock has a market capitalization of £4.59 billion and a price-to-earnings ratio of 7,486.67. The stock’s 50 day moving average price is GBX 214.79 and its two-hundred day moving average price is GBX 218.50. The company has a debt-to-equity ratio of 90.81, a quick ratio of 0.96 and a current ratio of 1.49. ConvaTec Group has a 52 week low of GBX 165.30 ($1.90) and a 52 week high of GBX 256 ($2.95).

Insider Transactions at ConvaTec Group

In related news, insider Constantin Coussios acquired 9,861 shares of the company’s stock in a transaction dated Friday, September 30th. The shares were bought at an average price of GBX 205 ($2.36) per share, for a total transaction of £20,215.05 ($23,275.82). In other ConvaTec Group news, insider Sten Scheibye bought 20,000 shares of the firm’s stock in a transaction that occurred on Monday, August 15th. The shares were acquired at an average cost of GBX 237 ($2.73) per share, with a total value of £47,400 ($54,576.86). Also, insider Constantin Coussios bought 9,861 shares of the firm’s stock in a transaction that occurred on Friday, September 30th. The shares were acquired at an average cost of GBX 205 ($2.36) per share, for a total transaction of £20,215.05 ($23,275.82).

ConvaTec Group Company Profile

(Get Rating)

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

Featured Articles

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.